2 ms·
unpatentable. Check the date: https://www.ncbi.nlm.nih.gov/pubmed/22390171 https://www.ncbi.nlm.nih.gov/pubmed/22390171 Also the mechanism of action is baroq
by dnautics 13y ago
unpatentable. Check the date:
https://www.ncbi.nlm.nih.gov/pubmed/22390171 https://www.ncbi.nlm.nih.gov/pubmed/22390171
Also the mechanism of action is baroque (although the compound class has fewer side effects), standard pharma is mostly interested in flashy new types of anticancer mechanisms.